Additional information
| Trade Name | ERBITUX 5 |
|---|---|
| Generic Name | Cetuximab |
| Manufacturer | Merck |
| Drug Type | Oncology |
| Indication | colorectal cancer |
| Doasage Form | Injectible |
| Packaging | 1 x 20ml / 5mg ml |
| Strength | 20ml, 100ml |
ERBITUX 5 (Cetuximab)
₹1.00 – ₹2.00
ERBITUX 5 (Cetuximab) belongs to a class of drugs known as monoclonal antibodies. An “anti-neoplastic”, it works by blocking the function of a protein called the epidermal growth factor receptor (EGFR) that is found on the surface of many cancer cells as well as normal cells.
It is indicated for
- care for patients with RAS wild-type metastatic colorectal cancer (CRC)
- Squamous Cell Cancer of the Head and Neck
- Non-small Cell Lung Cancer
- Squamous Cell Skin Cancer
Available in Strengths of 20ml & 100ml
